2019 Hemostasis Diagnostics Market: Market Shares by Country and Strategic Assessments of Leading Suppliers
This new 795-page report from contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic Technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of five POC market segments, including their dynamics, trends, structure,
size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for major infectious disease tests
by market segment:
- Physician Offices/Group Practices
- Emergency Rooms
- Ambulatory Care Centers
- Surgery Centers
- Birth Centers
Sales and Market Share Analysis
- Market shares of major infectious disease diagnostic reagent and instrument suppliers.
Current and Emerging Products
- Analysis of infectious disease diagnostic tests performed in POC testing locations.
- Review of leading infectious disease testing analyzers, both currently marketed and
those in development, including their operating characteristics, features and selling prices.
Technology Review
- Emerging Technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation
testing Technologies and products, by assay.
Competitive Assessments
- Assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, joint ventures,
and new products in R&D.
Strategic Recommendations
- Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and proprietary data files.
Copyright VENTURE PLANNING GROUP
This material is confidential for use by our clients only
and may not be reprinted or reproduced.
- Abbott
- ADI/American Diagnostica
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data Corporation
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- Hyphen BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fisher
- ZyCare/Alere
List Of Tables
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen
Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrands
Factor Tests
2020 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 POC Hemostasis Diagnostics Market Supplier Shares Sales Segment Forecasts Physician Offices Emergency Rooms Operating Suites ICUs/CCUs Cancer Clinics Ambulatory
2024 POC Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts--Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers This new
USD 3500 View Report2024 U.S. Hospital Hemostasis Diagnostics Market Supplier Shares Sales Segment Forecasts
2024 U.S. Hospital Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts This new report from .com is available by section, and can be customized to specific information needs
USD 3850 View ReportFill The Form For Sample Request